PH

Pookalathu Hyma

Active Director Designated Partner DIN 10153628
DIN 10153628 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Pookalathu Hyma

Data last updated:

Pookalathu Hyma is a Designated Partner at Swastik Aastha Infra Llp (since 2025) and Director at Df Endoklinic.In Private Limited (since 2023).

DIN 10153628
Primary Designation Designated Partner
First Appointment 08 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Mar 20252025Active
Df Endoklinic.In Private Limited U86100KL2023PTC081302
Director08 May 20232023Active

Board colleagues of Pookalathu Hyma

Directorship timeline

Open interactive timeline →
Df Endoklinic.In Private Limited
Swastik Aastha Infra Llp
Premium access

Shareholding and investment profile for Pookalathu Hyma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pookalathu Hyma

Pookalathu Hyma currently holds 2 directorships: Swastik Aastha Infra Llp (Designated Partner, since 22 Mar 2025); Df Endoklinic.In Private Limited (Director, since 08 May 2023).

Pookalathu Hyma was first appointed on 08 May 2023 as Director at Df Endoklinic.In Private Limited. The most recent appointment on record is 22 Mar 2025 at Swastik Aastha Infra Llp.

The current boards of Pookalathu Hyma's companies include Nithyananda Poojary (Swastik Aastha Infra Llp), Alur Ramaj (Df Endoklinic.In Private Limited), Faizal Mohammed Ikbal (Df Endoklinic.In Private Limited), Jasmin Faizal (Df Endoklinic.In Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available